BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 17660462)

  • 1. Blood-derived gene-expression profiling in unravelling susceptibility to recessive disease.
    Vahteristo P; Kokko A; Saksela O; Aittomäki K; Aaltonen LA
    J Med Genet; 2007 Nov; 44(11):718-20. PubMed ID: 17660462
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Pigmentary lesions in patients with increased DNA damage due to defective DNA repair].
    Krieger L; Berneburg M
    Ann Dermatol Venereol; 2012 Nov; 139 Suppl 3():S78-82. PubMed ID: 23260522
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Argyrophilic nucleolar organizing regions in patients with Xeroderma Pigmentosum Group E.
    Karagun E; Eroz R
    Exp Dermatol; 2021 Mar; 30(3):416-417. PubMed ID: 33200418
    [No Abstract]   [Full Text] [Related]  

  • 4. Abnormal regulation of DDB2 gene expression in xeroderma pigmentosum group E strains.
    Itoh T; Nichols A; Linn S
    Oncogene; 2001 Oct; 20(48):7041-50. PubMed ID: 11704828
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Xeroderma pigmentosum group E and DDB2, a smaller subunit of damage-specific DNA binding protein: proposed classification of xeroderma pigmentosum, Cockayne syndrome, and ultraviolet-sensitive syndrome.
    Itoh T
    J Dermatol Sci; 2006 Feb; 41(2):87-96. PubMed ID: 16325378
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ultraviolet-specific mutations in p53 gene in skin tumors in xeroderma pigmentosum patients.
    Sato M; Nishigori C; Zghal M; Yagi T; Takebe H
    Cancer Res; 1993 Jul; 53(13):2944-6. PubMed ID: 8319200
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased susceptibility to ultraviolet-B and carcinogens of mice lacking the DNA excision repair gene XPA.
    de Vries A; van Oostrom CT; Hofhuis FM; Dortant PM; Berg RJ; de Gruijl FR; Wester PW; van Kreijl CF; Capel PJ; van Steeg H; Verbeek SJ
    Nature; 1995 Sep; 377(6545):169-73. PubMed ID: 7675086
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Xeroderma pigmentosum genes: functions inside and outside DNA repair.
    Sugasawa K
    Carcinogenesis; 2008 Mar; 29(3):455-65. PubMed ID: 18174245
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mouse model for the DNA repair/basal transcription disorder trichothiodystrophy reveals cancer predisposition.
    de Boer J; van Steeg H; Berg RJ; Garssen J; de Wit J; van Oostrum CT; Beems RB; van der Horst GT; van Kreijl CF; de Gruijl FR; Bootsma D; Hoeijmakers JH; Weeda G
    Cancer Res; 1999 Jul; 59(14):3489-94. PubMed ID: 10416615
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development and field-test validation of an assay for DNA repair in circulating human lymphocytes.
    Athas WF; Hedayati MA; Matanoski GM; Farmer ER; Grossman L
    Cancer Res; 1991 Nov; 51(21):5786-93. PubMed ID: 1933849
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Xeroderma pigmentosum: from symptoms and genetics to gene-based skin therapy.
    Magnaldo T; Sarasin A
    Cells Tissues Organs; 2004; 177(3):189-98. PubMed ID: 15388993
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DNA repair and its possible involvement in the origin of multiple cancer.
    Takebe H; Tatsumi K; Satoh Y
    Jpn J Clin Oncol; 1985 Apr; 15 Suppl 1():299-305. PubMed ID: 4009991
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Xeroderma pigmentosum variant with multisystem involvement.
    Hessel A; Siegle RJ; Mitchell DL; Cleaver JE
    Arch Dermatol; 1992 Sep; 128(9):1233-7. PubMed ID: 1519938
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Xeroderma pigmentosum: clonal chromosomal rearrangements in a pre-cancerous skin lesion.
    Chessa L; Nuzzo F; Stefanini M; Lagomarsini P; del Porto G
    Dis Markers; 1990; 8(3):125-36. PubMed ID: 2272148
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Retrovirus-mediated gene transfer corrects DNA repair defect of xeroderma pigmentosum cells of complementation groups A, B and C.
    Zeng L; Quilliet X; Chevallier-Lagente O; Eveno E; Sarasin A; Mezzina M
    Gene Ther; 1997 Oct; 4(10):1077-84. PubMed ID: 9415314
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New mutation in the CYLD gene within a family with Brooke-Spiegler syndrome.
    Scholz IM; Nümann A; Froster UG; Helmbold P; Enk AH; Näher H
    J Dtsch Dermatol Ges; 2010 Feb; 8(2):99-101. PubMed ID: 20151946
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitative determination of the expression of xeroderma pigmentosum F gene in human nonmelanoma skin cancers.
    Chang LC; Sheu HM; Huang YS; Kuo KW
    Biochem Biophys Res Commun; 2000 Jul; 273(2):454-8. PubMed ID: 10873627
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of a human DNA excision repair gene involved in group A xeroderma pigmentosum and containing a zinc-finger domain.
    Tanaka K; Miura N; Satokata I; Miyamoto I; Yoshida MC; Satoh Y; Kondo S; Yasui A; Okayama H; Okada Y
    Nature; 1990 Nov; 348(6296):73-6. PubMed ID: 2234061
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Xeroderma pigmentosum.
    Lambert WC; Kuo HR; Lambert MW
    Dermatol Clin; 1995 Jan; 13(1):169-209. PubMed ID: 7712643
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Xeroderma pigmentosum patients belonging to complementation group F and efficient liquid-holding recovery of ultraviolet damage.
    Nishigori C; Fujisawa H; Uyeno K; Kawaguchi T; Takebe H
    Photodermatol Photoimmunol Photomed; 1991 Aug; 8(4):146-50. PubMed ID: 1814424
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.